Patents by Inventor Tania Hubbard

Tania Hubbard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine derivatives
    Patent number: 5843966
    Abstract: The present invention relates to piperidine derivatives of formula (I) ##STR1## wherein R.sup.1 is a C.sub.1-4 alkoxy group; R.sup.2 is ##STR2## R.sup.3 is a hydrogen or halogen atom; R.sup.4 and R.sup.5 may each independently represent a hydrogen or halogen atom, or a C.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl group;R.sup.6 is a hydrogen atom, a C.sub.1-4 alkyl, (CH.sub.2).sub.m cyclopropyl, --S(O).sub.n C.sub.1-4 alkyl, phenyl, NR.sup.7 R.sub.8, CH.sub.2 C(O)CF.sub.3 or trifluoromethyl group;R.sup.7 and R.sup.8 may each independently represent a hydrogen atom, or a C.sub.1-4 alkyl or acyl group;x represents zero or 1;n represents zero, 1 or 2;m represents zero or 1;and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation; and their use in the treatment of conditions mediated by tachykinins.
    Type: Grant
    Filed: July 23, 1997
    Date of Patent: December 1, 1998
    Assignee: Glaxo Group Limited
    Inventors: Duncan Robert Armour, Brian Evans, David Middlemiss, Tania Hubbard, Michael Menteith Hann, Xiao-Qing Lewell, Stephen Paul Watson, Alan Naylor, Neil Anthony Pegg, Maria Victoria Vinader, Gerard Martin Paul Giblin
  • Piperidine derivatives
    Patent number: 5703240
    Abstract: The present invention relates to piperidine derivatives of formula (I) ##STR1## wherein R.sup.1 is a C.sub.1-4 alkoxy group; R.sup.2 is ##STR2## R.sup.3 is a hydrogen or halogen atom; R.sup.4 and R.sup.5 may each independently represent a hydrogen or halogen atom, or aC.sub.1-4 alkyl, C.sub.1-4 alkoxy or trifluoromethyl group;R.sup.6 is a hydrogen atom, a C.sub.1-4 alkyl, (CH.sub.2).sub.m cyclopropyl, --S(O).sub.n C.sub.1-4 alkyl, phenyl,NR.sup.7 R.sup.8, CH.sub.2 C(O)CF.sub.3 or trifluoromethyl group;R.sup.7 and R.sup.8 may each independently represent a hydrogen atom, or a C.sub.1-4 alkyl or acyl group;x represents zero or 1;n represents zero, 1 or 2;m represents zero or 1;and pharmaceutically acceptable salts and solvates thereof; to processes for their preparation; and their use in the treatment of conditions mediated by tachykinins.
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: December 30, 1997
    Assignee: Glaxo Group Limited
    Inventors: Duncan Robert Armour, Brian Evans, David Middlemiss, Alan Naylor, Neil Anthony Pegg, Maria Victoria Vinader, Gerard Martin Paul Giblin, Tania Hubbard, Michael Menteith Hann, Xiao-Qing Lewell, Stephen Paul Watson